Successful combination of selpercatinib and radioiodine after pretherapeutic dose estimation in RET-altered thyroid carcinoma
Please always quote using this URN: urn:nbn:de:bvb:20-opus-324435
- No abstract available.
| Author: | Rudolf A. WernerORCiD, Cyrus Sayehli, Heribert Hänscheid, Takahiro Higuchi, Sebastian E. Serfling, Martin FassnachtORCiD, Maria-Elisabeth Goebeler, Andreas K. Buck, Matthias Kroiss |
|---|---|
| URN: | urn:nbn:de:bvb:20-opus-324435 |
| Document Type: | Journal article |
| Faculties: | Medizinische Fakultät / Klinik und Poliklinik für Nuklearmedizin |
| Medizinische Fakultät / Medizinische Klinik und Poliklinik I | |
| Language: | English |
| Parent Title (English): | European Journal of Nuclear Medicine and Molecular Imaging |
| Year of Completion: | 2023 |
| Volume: | 50 |
| Issue: | 6 |
| Pagenumber: | 1833-1834 |
| Source: | European Journal of Nuclear Medicine and Molecular Imaging (2023) 50:6, 1833-1834 DOI: 10.1007/s00259-022-06061-8 |
| DOI: | https://doi.org/10.1007/s00259-022-06061-8 |
| Dewey Decimal Classification: | 6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit |
| Tag: | combination; papillary thyroid carcinoma (PTC); radioiodine; selpercatinib; thyroid carcinoma (TC) |
| Release Date: | 2024/02/28 |
| Licence (German): |  CC BY: Creative-Commons-Lizenz: Namensnennung 4.0 International |